Drug intelligence / Profile preview

feng han gan mao ke li

Development stage
Unknown
Lead developer
Shandong Kongfu Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Feng Han Gan Mao Ke Li is a Traditional Chinese Medicine (TCM) granule formulation developed and manufactured by Shandong Kongfu Pharmaceutical. It is specifically indicated for the treatment of the "wind-cold" type of common cold, which is characterized by symptoms such as aversion to cold, fever without sweating, headache, nasal congestion, runny nose, and cough with thin white phlegm. The formulation is a complex mixture of herbal extracts, typically including Ephedra (麻黄), Pueraria (葛根), and Perilla leaf (紫苏叶), which work synergistically to induce diaphoresis, dispel cold, and ventilate the lungs. Pharmacologically, the product exhibits antipyretic, anti-inflammatory, and antitussive properties, partly mediated by adrenergic receptor agonism from its ephedrine content. It is an approved pharmaceutical product in China.

Brand names
Feng Han Gan Mao Ke Li
Other names
Wind-Cold Cold Granules风寒感冒颗粒
02

Targets

ADRA1 (Alpha-1 adrenergic receptor family)ADRB1 (β1)

Beyond the preview

Go deeper on feng han gan mao ke li.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on feng han gan mao ke li.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call